Cerebral Vasospasm

• CLINICAL_TRIALS trial_result · 2009-09-03
  Clinical Trial Update: Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study [Phase 4]

  Phase 4 trial evaluating eicosapentaenoic acid for cerebral vasospasm following subarachnoid hemorrhage has completed.

• CLINICAL_TRIALS trial_result · 2008-10-16
  Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm [Phase 1, Phase 2]

  This update reports on a randomized, double-blind, placebo-controlled Phase 1/2 trial evaluating simvastatin for subarachnoid hemorrhage-ind…

• FDA approval · 2008-01-17
  FDA Approved: NIMODIPINE — Original Application (BIONPHARMA INC.)

  FDA approves Bionpharma's nimodipine generic under an original ANDA, enabling market entry for this calcium channel blocker. Nimodipine is i…

• FDA approval · 2007-05-02
  FDA Approved: NIMODIPINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved the original application for nimodipine as a generic product from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.…